Molbio Diagnostics shares list at 21% premium at ₹980
Molbio Diagnostics debuted on the stock market on Monday with shares listing at ₹980 on both the BSE and NSE, a premium of 21.4 per cent over the issue price of ₹807.…
Molbio Diagnostics debuted on the stock market on Monday with shares listing at ₹980 on both the BSE and NSE, a premium of 21.4 per cent over the issue price of ₹807.…
Molbio Diagnostics' IPO opens today at Rs 768-807 per share to raise up to Rs 940 crore. The company makes the Truenat portable diagnostic platform, endorsed by WHO for tuberculosis testing and…